Proinflammatory cytokines and interleukin-9 exacerbate excitotoxic lesions of the newborn murine neopallium

Annals of Neurology

Volumn 47, Issue 1, 2000, Pages 54-63

  Dommergues, Marie Aliette ^a   Patkai, Juliana ^a   Renauld, Jean Christophe ^b   Evrard, Philippe ^a   Gressens, Pierre ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IBOTENIC ACID; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 9; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN INJURY; BRAIN TISSUE; CEREBRAL PALSY; EPIDEMIOLOGICAL DATA; FETOMATERNAL TRANSFUSION; GENE OVEREXPRESSION; GLOBUS PALLIDUS; HYPOTHESIS; MOUSE; NEWBORN; NONHUMAN; PERINATAL MORTALITY; PRIORITY JOURNAL; RISK FACTOR; TRANSGENE;

ANIMALS; BODY TEMPERATURE; BODY WEIGHT; BRAIN; CYTOKINES; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-9; MICE; NEUROTOXINS;

EID: 0033976956     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(200001)47:1<54::AID-ANA10>3.0.CO;2-Y     Document Type: Article

References (55)

1. Hagberg B, Hagberg G, Olow I, Wendt L. The changing panorama of cerebral palsy in Sweden. VII. Prevalence and origin in the birth year period 1987-90. Acta Paediatr 1996;85:954-960
2. Nelson KB, Ellenberg JH. Antecedents of cerebral palsy: multivariate analysis of risk. N Engl J Med 1986;315:81-86
3. Nelson KB, Dambrosia JM, Grether JK, Phillips TM. Neonatal cytokines and coagulation factors in children with cerebral palsy. Ann Neurol 1998;44:665-675
4. Evrard P, Marret S, Gressens P. Environmental and genetic determinants of neural migration and postmigratory survival. Acta Paediatr Scand Suppl 1997;422:20-26
5. McDonald JW, Johnston MV. Physiological and pathophysiological roles of excitatory amino acids during central nervous system development. Brain Res Rev 1990;15:41-70
6. Murphy DJ, Sellers S, MacKenzie IZ, et al. Case-control study of antenatal and intrapartum risk factors for cerebral palsy in very pretem singleton babies. Lancet 1995;346:1449-1454
7. Zupan V, Gonzalez P, Lacaze-Masmonteil T, et al. Periventricular leukomalacia: risk factors revisited. Dev Med Child Neurol 1996;38:1061-1067
8. Volpe JJ. Neurology of the newborn. Philadelphia: WB Saunders, 1995
9. Qiu Z, Sweeney DD, Netzeband JG, Gruol DL. Chronic interleukin-6 alters NMDA receptor-mediated membrane responses and enhances neurotoxicity in developing CNS neurons. J Neurosci 1998;18:10445-10456
10. Perlman JM, Risser R, Broyles RS. Bilateral cystic periventricular leukomalacia in the premature infant: associated risk factors. Pediatrics 1996;97:822-827
11. Gilles FH, Averill D, Kerre CS. Neonatal endotoxin encephalopathy. Ann Neurol 1977;2:49-56
12. Young RSK, Yagel SK, Towfighi J. Systemic and neuropathologic effects of E coli endotoxin in neonatal dogs. Pediatr Res 1983;17:349-353
13. Yoon BH, Kim CJ, Romero R, et al. Experimentally induced intrauterine infection causes fetal brain white matter lesions in rabbits. Am J Obstet Gynecol 1997;177:797-802
14. Hillier SL, Witkin SS, Krohn MA, et al. The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis, and chorioamnion infection. Obstet Gynecol 1993;81:941-948
15. Greig PC, Ernest JM, Teot L, et al. Amniotic fluid interleukin-6 levels correlate with histologic chorioamnionitis and amniotic fluid cultures in patients in premature labor with intact membranes. Am J Obstet Gynecol 1993;169:1035-1044
16. Romero R, Avila C, Santhanam U, Sehgal PB. Amniotic fluid interleukin-6 in preterm labor: association with infection. J Clin Invest 1990;85:1392-1400
17. Singh B, Merchant P, Walker CR, et al. Interleukin-6 expression in cord blood of patients with clinical chorioamnionitis. Pediatr Res 1996;39:976-979
18. Lencki SG, Maciulla MB, Eglinton GS. Maternal and umbilical cord serum interleukin levels in preterm labor with clinical chorioamnionitis. Am J Obstet Gynecol 1994;170:1345-1351
19. Martinez E, Figueroa R, Carry D, et al. Elevated amniotic fluid interleukin-6 as a predictor of neonatal periventricular leukomalacia and intraventricular hemorrhage. J Maternal Fetal Invest 1998;8:101-107
20. Yoon BH, Jun JK, Romero R, et al. Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1 beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy Am J Obstet Gynecol 1997;177:19-26
21. Yoon BH, Romero R, Yang SH, et al. Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am J Obstet Gynecol 1996;174:1433-1440
22. Marret S, Mukendi R, Gadisseux JF, et al. Effect of ibotenate on brain development: an excitotoxic mouse model of microgyria and posthypoxic-like lesions. J Neuropathol Exp Neurol 1995;54:358-370
23. Marret S, Bonnier C, Raymaekers JM, et al. Systemic administration of anti-NOS and anti-glycine protects against excitotoxic lesions in the developing mouse brain. Pediatr Res 1999; 45:337-341
24. Gressens P, Marret S, Hill JM, et al. Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brain. J Clin Invest 1997;100:390-397
25. Redecker C, Lutzenburg M, Gressens P, et al. Patterns of excitability changes and glucose metabolism in experimentally induced cortical dysplasias. Cereb Cortex 1998;8:623-634
26. Bac P, Maurois P, Dupont C, et al. Magnesium-deficiency-dependent audiogenic seizures (MDDASs) in adult mice: a nutritional model for discriminatory screening of anticonvulsant drugs and original assessment of neuroprotection properties. J Neurosci 1998;18:4363-4373
27. Sheng M, Cummings J, Roldan LA, et al. Changing subunit composition of heteromeric NMDA receptors during development of rat cortex. Nature 1994;368:144-147
28. Wang C, Pralong WF, Schulz MF, et al. Functional N-methyl-D-aspartate receptors in O-2A glial precursor cells: a critical role in regulating polysialic acid-neural cell adhesion molecule expression and cell migration. J Cell Biol 1996;135:1565-1581
29. Renauld JC, van der Lugt N, Vink A, et al. Thymic lymphomas in interleukin 9 transgenic mice. Oncogene 1994;9:1327-1332
30. Stefferl A, Hopkins SJ, Rothwell NJ, Luheshi GN. The role of TNF-alpha in fever: opposing actions of human and murine TNF-alpha and interactions with IL-beta in the rat. Br J Pharmacol 1996;118:1919-1924
31. Miller AJ, Luheshi GN, Rothwell NJ, Hopkins SJ. Local cytokine induction by LPS in the rat air pouch and its relationship to the febrile response. Am J Physiol 1997;272:857-861
32. Roe SY, Cooper AL, Morris ID, et al. Involvement of cytokines in cachexia induced by T-cell leukemia in the rat. Eur Cytokine Netw 1997;8:45-49
33. Nakanishi H, Katsuta K, Koide T, et al. Protective effect of FR115427 against ischemic hippocampal damage in gerbils. Jpn J Pharmacol 1994;64:189-193
34. Marty S, Dussart I, Peschanski M. Glial changes following an excitotoxic lesion in the CNS: I. Microglia/macrophages. Neuroscience 1991;45:529-539
35. Banks WA, Kastin AJ, Guttierez EG. Penetration of interleukin-6 across the murine blood-brain barrier. Neurosci Lett 1994;179:53-56
36. Wright JL, Merchant RE. Blood-brain barrier changes following intracerebral injection of human recombinant tumor necrosis factor-alpha in the rat. J Neurooncol 1994;20:17-25
37. Saija A, Princi P, Lanza M, et al. Systemic cytokine administration can affect blood-brain barrier permeability in the rat. Life Sci 1995;56:775-784
38. Risau W, Wolburg H. Development of the blood-brain barrier. Trends Neurosci 1990;13:174-178
39. Brenneman DE, Phillips TM, Festoff BW, Gozes I. Identity of neurotrophic molecules released from astroglia by vasoactive intestinal peptide. Ann NY Acad Sci 1997;814:167-173
40. Carlson NG, Bacchi A, Rogers SW, Gahring LC. Nicotine blocks TNF-α-mediated neuroprotection to NMDA by an α-bungarotoxin-sensitive pathway. J Neurobiol 1998;35:29-36
41. Ohtsuki T, Ruetzler CA, Tasaki K, Hallenbeck JM. Interleukin-1 mediates induction of tolerance to global ischemia in gerbil hippocampus CA1 neurons. J Cereb Blood Flow Metab 1996;16:1137-1142
42. Loddick SA, Turnbull AV, Rothwell NJ. Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat. J Cereb Blood Flow Metab 1998;18:176-179
43. Lawrence CB, Allan SM, Rothwell NJ. Interleukin-1 beta and the interleukin-1 receptor antagonist act in the striatum to modify excitotoxic brain damage in the rat. Eur J Neurosci 1998;10:1188-1195
44. Stroemer RP, Rothwell NJ. Exacerbation of ischemic brain damage by localized striatal injection of interleukin-1 beta in the rat. J Cereb Blood Flow Metab 1998;18:833-839
45. Merrill JE. Tumor necrosis factor alpha, interleukin 1 and related cytokines in brain development: normal and pathological. Dev Neurosci 1992;14:1-10
46. Lee SC, Dickson DW, Liu W, Brosnan CF. Induction of nitric oxide synthase activity in human astrocytes by interleukin-1 beta and interferon-gamma. J Neuroimmunol 1993;46:19-24
47. Iadecola C. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci 1997;20:132-139
48. Gunn AJ, Gunn TR, de Haan HH, et al. Dramatic neuronal rescue with prolonged selective head cooling after ischemia in fetal lambs. J Clin Invest 1997;99:248-256
49. Grundy RI, Rothwell NJ, Allan SM. Dissociation between the effects of interleukin-1 on excitotoxic brain damage and body temperature in the rat. Brain Res 1999;29:32-37
50. Caggiano AO, Kraig RP. Prostaglandin E2 and 4-amino-pyridine prevent the lipopolysaccharide-induced outwardly rectifying potassium current and interleukin-1β production in cultured rat microglia. J Neurochem 1998;70:2357-2368
51. Katayama Y, Maeda T, Koshinaga M, et al. Role of excitatory amino acid-mediated ionic fluxes in traumatic brain injury. Brain Pathol 1995;5:427-435
52. Demoulin JB, Renauld JC. Interleukin-9 and its receptor: an overview of structure and function. Int Rev Immunol 1998;16: 345-364
53. Godfraind C, Louahed J, Faulkner H, et al. Intraepithelial infiltration by mast cells with both connective tissue-type and mucosal-type characteristics in gut, trachea, and kidneys of IL-9 transgenic mice. J Immunol 1998;160:3989-3996
54. Dimitriadou V, Rouleau A, Trung Tuon MD, et al. Rat cerebral mast cells undergo phenotypic changes during development. Dev Brain Res 1996;97:29-41
55. Gordon JR, Burd PR, Galli SJ. Mast cells as a source of multifunctional cytokines. Immunol Today 1990;11:458-464